At Veratrak, we are team players who believe that technology has the power to drive better patient outcomes and contribute to making medicines more affordable.

Our future starts with you

Veratrak is an award-winning UK-based software company that has been at the forefront of digital transformation since 2018. We are dedicated to transforming the pharmaceutical supply chain with innovative solutions, and are always on the lookout for team members whose values align with ours.

As we embark on an exciting phase of growth, we’re expanding the team and seeking to fill several key roles. 

Equal Opportunities

We recognise the immense value that a diverse team brings to our organisation, fostering innovation, creativity, and greater productivity. Veratrak supports equal opportunities in employment and opposes all forms of unlawful discrimination on grounds such as colour, race, nationality, ethnic or national origin, sex, marital status, disability, sexual orientation, religion or belief, and age.

Read more about our commitment to diversity, equity, and inclusion (DEI).

Don't see a current opening that fits your experience?

Feel free to send a CV and cover letter outlining how you can contribute to Veratrak's mission 

News, Events & Insights

Here’s what we have been up to

Webinar: Optimising Your Scope 3 Emissions Reporting

We invite you to register to our upcoming webinar: "Optimising Your Scope 3 Emissions Reporting Across your Supply Chain" on Tuesday 7 May 2024, at 2:...

Supply Chain 4.0: Building a Resilient Supply Chain Ecosystem

In a risk-averse sector like pharma, the conservative approach to implementing new technologies has resulted in a slower uptake of innovative digital ...

Celebrating International Women's Day 2024 at Veratrak

This week, we celebrated International Women's Day 2024 every day to showcase some of our team members. At Veratrak, we believe that a diverse workfor...

A data-driven approach to reducing your supply chain carbon footprint

The global supply chain has connected customers with drug product manufacturers and patients in need across the world, however the Biotech and Pharma ...